IBRX FINAL DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm’s Attorneys Before Aug. 29th Deadline in Securities Fraud Class Action
28 août 2023 13h31 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23, 2022...
IBRX CLASS ACTION REMINDER: Hagens Berman Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending
31 juil. 2023 11h36 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, July 31, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23, 2022...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Notifies ImmunityBio (IBRX) Investors of Application Deadline in Securities Fraud Class Action, Encourages Investors with Substantial Losses to Contact Firm’s Attorneys
24 juil. 2023 12h01 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, July 24, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23,...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed
17 juil. 2023 11h56 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, July 17, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23, 2022...
IBRX SHAREHOLDER ALERT: Hagens Berman, National Trial Attorneys, Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending
12 juil. 2023 14h08 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, July 12, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23, 2022...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts ImmunityBio (IBRX) Investors to Securities Fraud Class Action, Encourages Investors with Substantial Losses to Contact Firm’s Attorneys
07 juil. 2023 09h31 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, July 07, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May...
IBRX ALERT: Hagens Berman, National Trial Attorneys, Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed
02 juil. 2023 11h25 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, July 02, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23, 2022...